← Leaderboards
Vladimir Mironov
Cardiovascular Tissue Technologies, Inc.
$393,263
Attributed
$393,263
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $124.3K · FY2005–06$200K$150K$100K$50K$0
'05
'06
Funding mix
By agency
NIH$393,263 · 2
By mechanism
P20$296,309 · 1
R43$96,954 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Tissue Engineering”
- Wesley Ian Sundquist · Utah State Higher Education System--University Of Utah$47,918,780
- Robert Stanley Sherwin · Yale University$43,700,325
- Gordana Vunjak-Novakovic · Tufts University Medford$36,226,687
- Louis J. Picker · Oregon Health And Science University$34,577,072
- Karl Alexander Deisseroth · Stanford University$34,039,874
- David S Perlin · Hackensack University Medical Center$33,316,814
Research focus
Tissue EngineeringAngiogenesisAngiogenesis InhibitorsBioengineering /Biomedical EngineeringBiotechnologyCartilage DevelopmentChondrocytesClinical ResearchElectron MicroscopyEmbolismAneurysmHemangiomaHistologyLaboratory RatMyocardiumPathologic ProcessPerfusionTechnology /Technique DevelopmentTissue /Cell CultureGenetics
Grant awards (4)
ENGINEERED VASCULARIZED PERFUSED 3-DIMENSIONAL MYOCARDIAL TISSUE CONSTRUCT$124,250
P20 · FY2006 · RR · contact PI
ENGINEERED VASCULARIZED PERFUSED 3-DIMENSIONAL MYOCARDIAL TISSUE CONSTRUCT$103,970
P20 · FY2005 · RR
ENGINEERED VASCULARIZED PERFUSED 3-D MYOCARDIAL TISSUE$68,089
P20 · FY2004 · RR
TISSUE ENGINEERING APPROACH, ENDOVASCULAR EMBOLIZATION$96,954
R43 · FY2000 · HL